Aino Health AB (AINO) AI Stock Analysis

• Market Cap: kr30.07M
• Dividend Yield: N/A
• Average Volume (3M): 37.35K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.79
• Revenue Growth: 10.03%
• EPS Growth: 66.78%
• Country: SE
• Employees: 19
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Healthcare Information Services
• EPS (TTM): -0.02
• Shares Outstanding: 204,569,100
• 10 Day Avg. Volume: 57,458
• 30 Day Avg. Volume: 37,353
• PEG Ratio: 0.07
• Price to Book (P/B): -75.15
• Price to Sales (P/S): 1.44
• P/FCF Ratio: -7.57
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 41 Neutral
• Price Target: kr0.17 ▼(-8.33% Downside)
• Action: Reiterated Date: 01/06/26
• Date: Action: Reiterated 01/06/26

The score is primarily weighed down by weak financial performance—persistent losses, negative equity, and consistently negative operating/free cash flow. Technicals add pressure with price below key moving averages and negative MACD, while valuation is constrained by a negative P/E and no provided dividend yield.

Positive Factors

Gross Margin Rebound

The sharp improvement in gross margin indicates enhanced operational efficiency, which could support future profitability if sustained.

Negative Factors

Negative Equity

Negative equity indicates financial instability, limiting the company's ability to raise capital and invest in growth opportunities.

Aino Health AB Business Overview & Revenue Model

Company Description

Aino Health AB (publ) provides corporate health management solutions for private and public organizations in Finland. It offers HealthManager, a software as a service solution that provides surveys, analytics, exposure checks, and security and GDP...

Read more

Aino Health AB (publ) provides corporate health management solutions for private and public organizations in Finland. It offers HealthManager, a software as a service solution that provides surveys, analytics, exposure checks, and security and GDP...

How the Company Makes Money

Aino Health AB generates revenue through a subscription-based model, where businesses pay for access to its digital health management platform. The platform provides tools and analytics that help organizations monitor and enhance employee health a...

Read more

Aino Health AB generates revenue through a subscription-based model, where businesses pay for access to its digital health management platform. The platform provides tools and analytics that help organizations monitor and enhance employee health a...

Aino Health AB Financial Statement Overview

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	26.56M	23.94M	23.92M	19.91M	23.04M	24.92M
Gross Profit	25.12M	21.51M	3.80M	17.77M	21.56M	23.61M
EBITDA	-2.36M	-6.21M	-7.53M	-12.26M	-12.09M	-9.95M
Net Income	-6.10M	-9.91M	-10.66M	-14.96M	-15.22M	-13.17M
Balance Sheet
Total Assets	7.43M	9.86M	13.51M	17.33M	19.02M	33.38M
Cash, Cash Equivalents and Short-Term Investments	834.00K	741.00K	1.44M	2.16M	453.00K	9.00M
Total Debt	836.00K	0.00	164.00K	659.00K	1.06M	1.49M
Total Liabilities	8.96M	10.32M	14.37M	19.57M	16.44M	17.36M
Stockholders Equity	-1.53M	-458.00K	-851.00K	-2.23M	2.58M	16.02M
Cash Flow
Free Cash Flow	-4.01M	-4.55M	-6.26M	-12.87M	-8.11M	-12.07M
Operating Cash Flow	-4.01M	-4.55M	-6.26M	-12.87M	-8.11M	-12.07M
Investing Cash Flow	-124.00K	0.00	0.00	1.32M	0.00	1.69M
Financing Cash Flow	4.78M	3.82M	5.57M	13.19M	-450.00K	16.38M

Aino Health AB Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 0.18
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:AINO, the sentiment is Neutral. The current price of 0.18 is above the 20-day moving average (MA) of 0.14, above the 50-day MA of 0.16, and below the 200-day MA of 0.19, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 49.77 is Neutral, neither overbought nor oversold. The STOCH value of 75.68 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for SE:AINO.

Aino Health AB Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
AINO	41 Neutral	kr30.07M	-5.72	209.66%	―	10.03%	66.78%